Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics.
Last Closing Price
January 24, 2018
J.P. Morgan, Cowen & Co.
To view the prospectus for Stemline Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277